Notify me when MAVERICK CAPITAL LTD files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| Infleqtion, Inc. | Common Stock, $0.0001 par value per share | 9.2% | 19,976,664 | Maverick Capital Management, LLC | 13 Feb 2026 | ||||
| IVVD | Invivyd, Inc. | Common Stock, $0.0001 par value per share | 6.7% | $47,806,701 | +$22,029,323 | 18,970,913 | +85% | Maverick Capital, Ltd. | 31 Dec 2025 |
| WVE | Wave Life Sciences Ltd. | $0 Par Value Ordinary Shares | 5.4% | $56,093,833 | 8,261,242 | Maverick Capital, Ltd. | 31 Dec 2024 | ||
| VRNA | Verona Pharma Plc | Ordinary Shares, nominal value 0.05 GBP per share | 3.8% | $1,638,341,259 | 25,028,128 | Maverick Capital, Ltd. | 31 Dec 2024 | ||
| BTU | Peabody Energy Corporation | Common Stock, par value $0.01 per share | 3.3% | $137,470,447 | -$138,250,112 | 4,067,173 | -50% | Maverick Capital, Ltd. | 31 Dec 2025 |
| GUTS | Fractyl Health, Inc. | Common Stock, $0.00001 par value per share | 3.1% | $6,755,102 | 4,248,492 | Maverick Capital, Ltd. | 30 Sep 2025 | ||
| RCKT | Rocket Pharmaceuticals, Inc. | Common stock, $0.01 par value per share | 2.3% | $9,549,818 | -$22,232,671 | 2,513,110 | -70% | Maverick Capital, Ltd. | 31 Dec 2025 |
| CRIS | Curis, Inc. | Common Stock, par value $0.01 per share | 0.4% | $82,260 | -$1,048,833 | 49,554 | -93% | Maverick Capital, Ltd. | 30 Sep 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|